The global nutraceutical market is valued at nearly USD 400 billion, bringing together the worlds of food, medicine, and science. It’s one of the fastest-growing industries today. Chemkart India, with its presence in the nutraceutical space, has been part of this journey. The company is taking a big step forward and going public. This move marks an exciting new chapter for Chemkart as it aims to grow.
The Chemkart India IPO lead manager is Smart Horizon Capital Advisors, while the registrar of this IPO is Bigshare Services Limited.
Check the RHP for more Chemkart India IPO details.
Note: For 50% of the shares, the anchor lock-in period expires 30 days following the actual allocation, and for the remaining part, it ends 90 days later.
Let’s take a look at the important information related to the Chemkart India IPO.
Check everything about the company before you go for the Chemkart India IPO subscription.
Take a look at the official IPO calendar to get a better Chemkart India IPO review.
Discover Chemkart IPO lot size here.
Understand the allocation strategy of Chemkart India.
Let’s walk through the important Chemkart India IPO share price details.
The bid limits for retail investors, HNIs, and QIBs have been clearly outlined here.
Open your Demat account today to apply for the Chemkart India IPO and start your investment journey without missing out!
Chemkart India IPO details: Key Financials
The numbers below reveal if margins and revenue are moving in the right direction.
Here’s a balanced review that brings out the full picture of the Chemkart India IPO for better decision-making.
Strengths
Located close to Mumbai port, so goods move quickly from the ship to storage.
Quick to spot trends, which helps launch new products faster than others.
Good ties with B2B clients bring repeat orders and steady relationships.
Covers many health product types, so it attracts a wide range of customers.
Risks
Negative cash flow in recent times might limit business growth.
Too much dependence on a few suppliers, and there are no binding deals in place.
Losing rented office space might affect daily work and bring extra costs.
Not much background in the health supplement field may affect quality checks or future plans.
At this point, the Chemkart India IPO GMP hasn’t been active. But be sure to check the Chemkart India share price and important deadlines so you don’t miss any steps before allotment.
Get started with your Chemkart India IPO allotment process today.
Chemkart India Limited is a Mumbai-based nutraceutical ingredients distributor established in 2020, supplying amino acids, herbal extracts, proteins, vitamins, sports nutrition, and nucleotides from a 28,259 sq ft warehousing facility near Mumbai port. The company reported total income of ₹20,545 lakhs in FY25 — 55% YoY growth — with PAT of ₹2,425 lakhs and EBITDA margin of 16.12%. Chemkart India IPO is a BSE SME issue combining fresh issue of ₹64.48 crore and OFS of ₹15.60 crore — total ₹80.18 crore — priced at ₹236–₹248 per share, listed on BSE SME on July 12, 2025.
